The practice of initiating immunomodulatory treatment immediately after a clinically isolated
syndrome (CIS) suggestive of multiple sclerosis (MS) emphasizes the need to distinguish …

… It has been studied as a treatment for multiple sclerosis (MS) for the past 30 years and is
used by physicians in selected cases of progressive or worsening MS. Review of published …

… Although immune mechanisms are often implicated in the cause of multiple sclerosis (MS) …
review will evaluate critically the evidence in favor of selected forms of this type of treatment. …

… The non-random geographic distribution of multiple sclerosis (MS) has provided considerable
allure for epidemiologic study since the patterns are believed to reflect underlying causes.…

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous
system (CNS) which can lead to severe disability. Several diseases can mimic the clinical …

… multiple sclerosis (SPMS) patients, the cortisol response to the neuropeptide was lower
than in primary progressive multiple sclerosis (… in relapsing remitting multiple sclerosis (RRMS) …

… Critical reviews often synthesize diverse sources of evidence rather than answering a
clinical question, and this review included a heterogeneous group of studies, many of which …

Interferon β and glatiramer acetate have been available for the treatment of multiple sclerosis
(MS) for over a decade and their efficacy and safety are well established. These agents …

… any, between allergy and multiple sclerosis. In order to evaluate … entities displaying the
multiple sclerosis syndrome and that the … for the diagnosis of multiple sclerosis, none has proved …

… This report summarises the discussions and recommendations of an international workshop
held to review critically the elements of current MS therapeutic trials and to identify the most …